Management of a patient with Opalski’s syndrome in intensive care unit and mini review of the literature

CASE REPORT

Hippokratia 2012, 16, 4: 373-374

Aslanidis T, Chytas I, Kontos A, Giannakou-Peftoulidou M
Intensive Care Unit, Department of Anesthesia and Intensive Care, AHEPA University Hospital, Thessaloniki, Greece.

Abstract

Stroke syndromes include a variety of syndromes with often overlapping clinical presentations. When ipsilateral hemiplegia is associated with symptoms of a lateral medullary syndrome, it corresponds to the submedullary syndrome of Opalski. A 72-year-old woman presented with sudden onset of headache, gait disturbance, and recurrent vomiting. Her clinical status gradually deteriorated and she was admitted to the intensive care unit where a variety of problems, related to her diagnosis (Opalski syndrome), were managed.

Keywords: Opalski syndrome, intensive care unit

Correspoding author: Theodoros Aslanidis, 4 Doridos street, 54633, Thessaloniki, Greece, tel.+306972477166, e-mail:thaslan@hotmail.com

Introduction

Lateral medullary infarction (Wallenberg’s syndrome) is a relatively common vertebrobasilar vascular syndrome. However, ipsilateral hemiparesis as part of lateral medullary infarction is rare, and is known as Opalski’s syndrome1. We present the management of a 72 year old female patient with Opalski syndrome in our intensive care unit.

Case report

A 72-year-old female patient (body weight 76 kg, height 160 cm, BMI 30.08 kg/cm2) was admitted to our intensive care unit after being hospitalized for 3 days in another general hospital. She presented to the Emergency Department there, with sudden onset of headache, gait disturbance, vertigo, and recurrent vomiting. Her past medical history included diabetes mellitus under insulin therapy with Lantus® 30 iu q.d. και Novorapid® 8-12-8 iu q.d., arterial hypertension under multi-antihypertensive regimen with perindropril 2.5 mg q.d., amlodipine 5 mg q.d., carvedilol 6.25 mg b.i.d and furosemide 20 mg q.d. Surgical history was unremarkable. Family history was non-contributory. She had no known drug allergies.

The next day her clinical status aggravated with tachycardia and an episode of atrial fibrillation, dysarthria and dysphagia, drooping of the right corner of mouth, nystagmus and reduced corneal reflex of the right eye. Computed Tomography (CT) with intravenous contrast media, revealed an isodense area without clear limits in the right cerebellopontine angle with nonhomogeneous perfusion, regional oedema and displacement of the 4th ventricle and brainstem to the left. A few hours later, the patient’s neurological status suddenly deteriorated (Glasgow Coma Scale –E2/V1/M6); she was intubated and transported to our hospital where a second CT was performed. The latter revealed a tension hydrocephalus and an infarction lesion in the right cerebellopontine angle. The 4th ventricle was not visualized. The patient was transported to the operating room where a valveless drain tube was placed in the anterior horn of the right lateral ventricleunder general anesthesia. Following surgery, she was admitted to intensive care unit (ICU).

In the ICU, the patient was placed under sedation with continuous intravenous infusion (c.i.v.) of propofol 25-35μg/kg/min and mechanical ventilation (FiO2 40%, PEEP 6 cmH2O, 10 breaths/min with a tidal volume of 6 ml/kg). Antiedemic regimen (dexamethasone 16 mg i.v. q.d., mannitol 20% 100ml i.v. q.i.d.), antimicrobial and antiulcer prophylaxis were administered; blood glucose was controlled via insulin protocol with bolus administrations. Hemodynamically, the patient was stable with atrial fibrillation and normal ventricular rate. Upon admission, a transcranial Doppler study and a transorbital optical nerve sheath ultrasonography were performed with normal findings.

On day 3, enteral nutrition was initiated and, in order to meet the increasing daily needs of insulin to maintain blood glucose between 100-150 mg/dl, insulin c.i.v. was started according to a sliding scale. Atrial fibrillation was managed with propranolol 40 mg p.os. t.i.d.. Mechanical ventilation parameters were also modified (PEEP 8 cm H2O) due to atetelectasis of the left lower pulmonary lobe. On day 5, a gradual dose reduction of antiedemic regimen was initiated. On day 7 transdermal tracheostomy was conducted and the next day a second computed tomography scan was performed revealing a significant reduction of hydrocephalus.

Based on the new radiological findings, sedation was stopped; an early neurologic evaluation was made (GCS E3/V1/M1 with normal pupils’ reaction to light). The following days de-escalation of mechanical support was achieved (change of mode to ASV followed by PSV), insulin administration was changed from c.i.v. to bolus i.v. as blood glucose control became more effective and nifedipine 30mg p.os (Levin) t.i.d. was added as antihypertensive therapy. On day 20, the patient became septic with fever (38.8oC), aggravating respiratory parameters, and hypotensive with sudden onset of paroxysmal atrial fibrillation (ventricular rate of 145-160 beats per min). An amiodarone infusion was started, blood cultures were performed and antibiotic regimen was changed. Progressively, the neurological state of the patient ameliorated and the hydrocephalus drain tube was removed. Laboratory cardiac indices of ischaemia and transthoracic echocardiography revealed no aberrations; yet, the patient remained dependent to amiodarone infusion. A cardiologist consultation was made and finally the rhythm was controlled with amiodarone 200mg p.os. b.i.d and atenolol 20 mg p.os. b.i.d. The patient was freed from mechanical ventilation (breathing through tracheostomy) and a full neurological evaluation was performed. The latter revealed GCS of E4/V1T/M6, with ipsilateral to the lesion hemiparesis, dysphagia, drooping of the right corner of mouth and reduced corneal reflex of the right eye. On day 38, the patient was transferred to the ward with the diagnosis of Opalski’s syndrome. The patient was stable during her stay in the ward and a transport to rehabilitation clinic was planned.

Discussion

Ipsilateral hemiparesis with symptoms and signs of lateral medullary infarction were first described by Opalski in 19462. Some pathologic and neuroradiologic reports have shown that the lesion is located lower than in Wallenberg syndrome caused by occlusion of the posterior inferior cerebellar artery. The ipsilateral hemiparesis seen in this syndrome is attributed to the involvement of corticospinal fibers caudal to the pyramidal decussation2. Others have explained these combined findings as a result of vertebral artery (VA) occlusion/stenosis or VAD, compromising the medullary penetrating arteries that arise from distal VAs or anterior spinal arteries3-5. Our patient had almost all neurological findings of the syndrome. The latter include -apart the ipsilateral hemiparesis- dysarthria and dysphagia (possible involvement of nucleus ambiguous to the lesion), nystagmus on the ipsilateral side (involvement of nucleus vestibularis inferior), tachycardia and dyspnoe (nucleus dorsalis nervi vagi), ataxia and muscle hypotonia (tractus spinocerebellaris anterior), loss of sensation of pain and temperature on the face, reduced corneal reflex on the ipsilateral side (nucleus tractus spinalis nervi trigemini), limb ataxia and asynergia (pedunculus cerebellaris inferior), ageusia (nucleus tractus solitarii), signultus (substantia reticularis), palatal myoclonus (tractus tegmentalis centralis) and loss of sensation of pain and temperature in the body and extremities (tractus spinothalamicus anterior)5-6.

Generally, the neurological findings are in accordance with pathological and radiological findings6, but differential diagnosis includes a variety of clinical identities, like Cestan-Chenais syndrome which include contralateral hemiparesis with symptoms and signs of lateral medullary infarction, the Babinski-Nageotte syndrome (hemimedullary infarct) in which the ipsilateral pyramidal tract is affected before decussation with contralateral hemiparesis, the Dejerine syndrome , where the lesion is in midoblongata, the Ménière disease, the Marie-Foix syndrome and others7-9.

Considering the possible involvement of multiple nerve structures, management of patients affected by the syndrome poses a considerable challenge. This case has given us an insight of this rare condition.

References

1. Kim HY, Koh SH, Lee KY, Lee YJ, Kim SH, Kim J, et al. Opalski’s Syndrome with cerebellar infarction. J Clin Neurol. 2006; 2: 276-278.
2. Opalski A. Un nouveau syndrome sous-bulbaire: syndrome partiel de l’artère vertébro-spinale postérieur. Paris Med. 1946; 1: 214-220.
3. Osetowska E, Krasnicka Z. Sur le syndrome sous-bulbaire d’Opalski avec une étude anatomique (contribution aux aspects paradoxaux du syndrome de Wallenberg). Rev Neurol. (Paris). 1961; 104: 314–320.
4. Dhamoon SK, Iqbal J, Collins GH. Ipsilateral hemiplegia and the Wallenberg syndrome. Arch Neurol. 1984; 41:179–180.
5. Liu CY, Chang FC, Hu HH, Hsu LC. Ipsilateral crural monoparesis in lateral medullary infarction due to vertebral artery dissection. Eur J Neurol. 2006; 13: e8-e9.
6. Bailon O, Garcia PY, Logak M, Timsit S. Opalski syndrome detected on DWI MRI: A rare lateral medullary infarction. Case report and review. Rev Neurol. (Paris). 2011; 167: 177-180.
7. Kumral E, Kisabay A, Ataç C, Calli C, Yunten N. Spectrum of the posterior inferior cerebellar artery territory infarcts. Clinical-diffusion-weighted imaging correlates. Cerebrovasc Dis. 2005; 20: 370-380.
8. Edlow JA, Selim MH. Atypical presentations of acute cerebrovascular syndromes. Lancet Neurol. 2011; 10: 550-560.
9. Montaner J, Alvarez-Sabín J. Opalski’s syndrome. J Neurol Neurosurg Psychiatry. 1999; 67: 688–689.